309 related articles for article (PubMed ID: 27668420)
1. Genetic disruption of the KLF1 gene to overexpress the γ-globin gene using the CRISPR/Cas9 system.
Shariati L; Khanahmad H; Salehi M; Hejazi Z; Rahimmanesh I; Tabatabaiefar MA; Modarressi MH
J Gene Med; 2016 Oct; 18(10):294-301. PubMed ID: 27668420
[TBL] [Abstract][Full Text] [Related]
2. Disruption of SOX6 gene using CRISPR/Cas9 technology for gamma-globin reactivation: An approach towards gene therapy of β-thalassemia.
Shariati L; Rohani F; Heidari Hafshejani N; Kouhpayeh S; Boshtam M; Mirian M; Rahimmanesh I; Hejazi Z; Modarres M; Pieper IL; Khanahmad H
J Cell Biochem; 2018 Nov; 119(11):9357-9363. PubMed ID: 30010219
[TBL] [Abstract][Full Text] [Related]
3. Three fingers on the switch: Krüppel-like factor 1 regulation of γ-globin to β-globin gene switching.
Tallack MR; Perkins AC
Curr Opin Hematol; 2013 May; 20(3):193-200. PubMed ID: 23474875
[TBL] [Abstract][Full Text] [Related]
4. KLF1 regulates BCL11A expression and gamma- to beta-globin gene switching.
Zhou D; Liu K; Sun CW; Pawlik KM; Townes TM
Nat Genet; 2010 Sep; 42(9):742-4. PubMed ID: 20676097
[TBL] [Abstract][Full Text] [Related]
5. Induction of adult levels of β-globin in human erythroid cells that intrinsically express embryonic or fetal globin by transduction with KLF1 and BCL11A-XL.
Trakarnsanga K; Wilson MC; Lau W; Singleton BK; Parsons SF; Sakuntanaga P; Kurita R; Nakamura Y; Anstee DJ; Frayne J
Haematologica; 2014 Nov; 99(11):1677-85. PubMed ID: 25107887
[TBL] [Abstract][Full Text] [Related]
6. Alterations on high HbF levels may be associated with KLF1 gene mutations.
Aydin M; Rencuzogullari E; Bayram S; Sevgiler Y; Genc A
Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):51-57. PubMed ID: 28886314
[TBL] [Abstract][Full Text] [Related]
7. Krüppel-Like Transcription Factor KLF1 Is Required for Optimal γ- and β-Globin Expression in Human Fetal Erythroblasts.
Vinjamur DS; Alhashem YN; Mohamad SF; Amin P; Williams DC; Lloyd JA
PLoS One; 2016; 11(2):e0146802. PubMed ID: 26840243
[TBL] [Abstract][Full Text] [Related]
8. Mild dyserythropoiesis and β-like globin gene expression imbalance due to the loss of histone chaperone ASF1B.
Papadopoulos P; Kafasi A; De Cuyper IM; Barroca V; Lewandowski D; Kadri Z; Veldthuis M; Berghuis J; Gillemans N; Benavente Cuesta CM; Grosveld FG; van Zwieten R; Philipsen S; Vernet M; Gutiérrez L; Patrinos GP
Hum Genomics; 2020 Oct; 14(1):39. PubMed ID: 33066815
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic dysregulation of the erythropoietic transcription factor KLF1 and the β-like globin locus in juvenile myelomonocytic leukemia.
Fluhr S; Krombholz CF; Meier A; Epting T; Mücke O; Plass C; Niemeyer CM; Flotho C
Epigenetics; 2017 Aug; 12(8):715-723. PubMed ID: 28749240
[TBL] [Abstract][Full Text] [Related]
10. Comparative targeting analysis of KLF1, BCL11A, and HBG1/2 in CD34
Lamsfus-Calle A; Daniel-Moreno A; Antony JS; Epting T; Heumos L; Baskaran P; Admard J; Casadei N; Latifi N; Siegmund DM; Kormann MSD; Handgretinger R; Mezger M
Sci Rep; 2020 Jun; 10(1):10133. PubMed ID: 32576837
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation of Krüppel-like factor 1 (KLF1) and fetal hemoglobin (HbF) levels in β
Khamphikham P; Sripichai O; Munkongdee T; Fucharoen S; Tongsima S; Smith DR
Int J Hematol; 2018 Mar; 107(3):297-310. PubMed ID: 29067594
[TBL] [Abstract][Full Text] [Related]
12. KLF1 stabilizes GATA-1 and TAL1 occupancy in the human β-globin locus.
Kang Y; Kim YW; Yun J; Shin J; Kim A
Biochim Biophys Acta; 2015 Mar; 1849(3):282-9. PubMed ID: 25528728
[TBL] [Abstract][Full Text] [Related]
13. Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta thalassemia disease.
Khosravi MA; Abbasalipour M; Concordet JP; Berg JV; Zeinali S; Arashkia A; Azadmanesh K; Buch T; Karimipoor M
Eur J Pharmacol; 2019 Jul; 854():398-405. PubMed ID: 31039344
[TBL] [Abstract][Full Text] [Related]
14. A novel mutation in the erythroid transcription factor KLF1 is likely responsible for ameliorating β-thalassemia major.
Fanis P; Kousiappa I; Phylactides M; Kyrri A; Hadjigavriel M; Christou S; Sitarou M; Kleanthous M
Hum Mutat; 2019 Oct; 40(10):1768-1780. PubMed ID: 31115947
[TBL] [Abstract][Full Text] [Related]
15. Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus.
Antoniani C; Meneghini V; Lattanzi A; Felix T; Romano O; Magrin E; Weber L; Pavani G; El Hoss S; Kurita R; Nakamura Y; Cradick TJ; Lundberg AS; Porteus M; Amendola M; El Nemer W; Cavazzana M; Mavilio F; Miccio A
Blood; 2018 Apr; 131(17):1960-1973. PubMed ID: 29519807
[TBL] [Abstract][Full Text] [Related]
16. Erythropoiesis and globin switching in compound Klf1::Bcl11a mutant mice.
Esteghamat F; Gillemans N; Bilic I; van den Akker E; Cantù I; van Gent T; Klingmüller U; van Lom K; von Lindern M; Grosveld F; Bryn van Dijk T; Busslinger M; Philipsen S
Blood; 2013 Mar; 121(13):2553-62. PubMed ID: 23361909
[TBL] [Abstract][Full Text] [Related]
17. Both TALENs and CRISPR/Cas9 directly target the HBB IVS2-654 (C > T) mutation in β-thalassemia-derived iPSCs.
Xu P; Tong Y; Liu XZ; Wang TT; Cheng L; Wang BY; Lv X; Huang Y; Liu DP
Sci Rep; 2015 Jul; 5():12065. PubMed ID: 26156589
[TBL] [Abstract][Full Text] [Related]
18. Transcription factors KLF1 and KLF2 positively regulate embryonic and fetal beta-globin genes through direct promoter binding.
Alhashem YN; Vinjamur DS; Basu M; Klingmüller U; Gaensler KM; Lloyd JA
J Biol Chem; 2011 Jul; 286(28):24819-27. PubMed ID: 21610079
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobin.
Ravi NS; Wienert B; Wyman SK; Bell HW; George A; Mahalingam G; Vu JT; Prasad K; Bandlamudi BP; Devaraju N; Rajendiran V; Syedbasha N; Pai AA; Nakamura Y; Kurita R; Narayanasamy M; Balasubramanian P; Thangavel S; Marepally S; Velayudhan SR; Srivastava A; DeWitt MA; Crossley M; Corn JE; Mohankumar KM
Elife; 2022 Feb; 11():. PubMed ID: 35147495
[TBL] [Abstract][Full Text] [Related]
20. Gamma reactivation using the spongy effect of KLF1-binding site sequence: an approach in gene therapy for beta-thalassemia.
Heydari N; Shariati L; Khanahmad H; Hejazi Z; Shahbazi M; Salehi M
Iran J Basic Med Sci; 2016 Oct; 19(10):1063-1069. PubMed ID: 27872702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
